Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Cancer patients who undergo PCI face a higher risk of early mortality

Overall, PCI patients appear to face a higher risk of in-hospital mortality, 30-day mortality and in-hospital cardiovascular mortality if they present with an active or historical cancer diagnosis. The group's analysis included data from nearly 6.6 million patients.

Three systems for left ventricular pacing during TAVR, modified TAVR valve delivery wire, the Opsens Savvy wire, and the Teleflex Wattson wire.

VIDEO: Use of temporary left ventricular pacing during TAVR procedures

Philippe Genereux, MD, medical director of the structural heart disease program at Morristown Medical Center, discusses the various options used for temporary pacing of the heart during transcatheter aortic valve replacement (TAVR) procedures.

Cardiologists make history, becoming first to use FDA-cleared retrieval device to remove a heart tumor

The historic procedure took approximately 30 minutes, and the patient went home that same day. 

Thumbnail

Moderate aortic stenosis linked to a significant risk of death—should earlier interventions be considered?

Researchers tracked data from more than 12,000 moderate AS patients who originally participated in one of 25 different studies. While the findings seem to suggest earlier treatment could be beneficial for certain high-risk patients, additional research is still required.

Thumbnail

Boston Scientific acquires startup behind new FDA-cleared embolization technology

The new hydrogel material was designed to immediately conform to the patient's body and create a barrier.

Harry Lee Page, Jr., MD, a veteran cardiologist who helped pioneer many modern interventional techniques, died on August 11 after a long illness. He was 88 years old. SCAI

‘The end of an era’: Influential cardiologist, dead at 88, made a lasting impact

“We are so fortunate to have had fearless luminaries such as Harry Page at the helm of our profession,” SCAI President Sunil V. Rao, MD, said in a statement.

Transcatheter mitral valve repair (TMVr) is associated with “promising” short-term outcomes among patients with a history of cancer, according to new research published in the American Journal of Cardiology.

Risk of death increases when TEER patients present with hypertrophic cardiomyopathy

A team of Cleveland Clinic researchers tracked data from nearly 23,000 patients, sharing their findings in the American Journal of Cardiology

Pre-procedure CT imaging benefits LAA occlusion in Henry Ford study

There is not agreement among the top structural heart experts if CT is required for left atrial appendage occlusion (LAAO), but a Henry Ford Hospital study shows it can improve outcomes.